SATO VICKI L 4
4 · Vir Biotechnology, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2025-01-08$12.52/sh−10,960$137,219→ 1,312,391 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024.